Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5895-5903
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5895
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5895
Figure 2 (-)-Epigallocatechin-3-gallate increases poly I:C-induced TLR3 and RIG-I mRNA expression in JFH-1-infected Huh7 cells.
JFH-1-infected Huh7 cells (72 h post-infection) were treated with (-)-epigallocatechin-3-gallate (EGCG) at the indicated concentrations for 1 h prior to poly I:C (1 μg/mL) stimulation. Total RNA extracted from the cells after 24 h of stimulation was evaluated for TLR3 (A) and RIG-I (B) gene expression by real-time RT-PCR. The results shown are the mean ± SD of triplicate measurements representative of three experiments (Poly I:C vs LyoVec, aP < 0.05, bP < 0.01). TLR3: Toll-like receptor 3; RIG-I: Retinoic acid-inducible gene I.
- Citation: Wang YZ, Li JL, Wang X, Zhang T, Ho WZ. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes. World J Gastroenterol 2017; 23(32): 5895-5903
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5895.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5895